Centerpoint Advisors’s GE HealthCare GEHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$12K Buy
190
+25
+15% +$1.64K ﹤0.01% 319
2026
Q1
$12K Hold
165
﹤0.01% 305
2025
Q4
$14K Hold
165
﹤0.01% 300
2025
Q3
$12K Hold
165
﹤0.01% 318
2025
Q2
$12K Sell
165
-2
-1% -$139 ﹤0.01% 303
2025
Q1
$13K Sell
167
-2
-1% -$172 ﹤0.01% 297
2024
Q4
$13K Sell
169
-12
-7% -$1.02K ﹤0.01% 328
2024
Q3
$17K Hold
181
0.01% 307
2024
Q2
$14K Sell
181
-164
-48% -$13.4K 0.01% 319
2024
Q1
$31K Sell
345
-43
-11% -$3.58K 0.01% 203
2023
Q4
$30K Sell
388
-14
-3% -$980 0.01% 189
2023
Q3
$27K Hold
402
0.01% 198
2023
Q2
$33K Hold
402
0.01% 192
2023
Q1
$33K Buy
+402
New +$28.7K 0.01% 199

Other funds holding GEHC

Centerpoint Advisors's GEHC Position: Q2 2026 in Review

Centerpoint Advisors increased its GE HealthCare (GEHC) stake by 15% in Q2 2026, buying an estimated $1.64K and bringing the position to 190 shares worth $12K. The position accounts for ﹤0.01% of the portfolio, ranked #319.

Centerpoint Advisors first reported a position in GEHC in Q1 2023 and has held it in 14 quarters since. The position peaked at $33K in Q2 2023. 1,226 funds tracked by Wall St. Rank hold GEHC as of Q2 2026.

  • Centerpoint Advisors held 190 shares of GE HealthCare worth $12K as of Q2 2026.
  • Centerpoint Advisors bought 25 GE HealthCare shares in Q2 2026, an estimated $1.64K.
  • GE HealthCare made up ﹤0.01% of Centerpoint Advisors's portfolio in Q2 2026, its #319 holding.
  • Centerpoint Advisors first reported a position in GE HealthCare in Q1 2023 and has held it in 14 quarters since.
  • Centerpoint Advisors's GE HealthCare position peaked at $33K in Q2 2023.
  • 1,226 funds tracked by Wall St. Rank held GE HealthCare as of Q2 2026.

Based on Centerpoint Advisors's 13F filing for Q2 2026, filed 5 Aug 2026.